# XBiotech Inc.: Form 10-K/A for the period ended Dec 31, 2018

- Company: [XBiotech Inc.](/companies/xbit.md) (CIK 1626878)
- Form: 10-K/A
- Filed: 2019-03-15
- Accepted by EDGAR: Mar 15, 2019, 13:09 ET
- Period: 2018-12-31
- Accession: 0001171843-19-001758
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1626878/000117184319001758/f10ka_031419p.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1626878/000117184319001758/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 12 months, 2018-01-01 to 2018-12-31 | $15.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2018-10-01 to 2018-12-31 | −$6.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months, 2018-01-01 to 2018-12-31 | −$21.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2018-01-01 to 2018-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-10-01 to 2018-12-31 | −$6.1m | us-gaap:NetIncomeLoss |
| Net income | 12 months, 2018-01-01 to 2018-12-31 | −$21.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-10-01 to 2018-12-31 | −$0.17 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months, 2018-01-01 to 2018-12-31 | −$16.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2018-01-01 to 2018-12-31 | $122.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2018-12-31 | $15.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-12-31 | $17.0m | us-gaap:AssetsCurrent |
| Total assets | at 2018-12-31 | $44.3m | us-gaap:Assets |
| Current liabilities | at 2018-12-31 | $2.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-12-31 | $2.9m | us-gaap:Liabilities |
| Shareholders' equity | at 2018-12-31 | $41.4m | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1626878/000117184319001758/f10ka_031419p.htm

Filed Mar 15, 2019.
Source: SEC EDGAR, the filing index for accession 0001171843-19-001758. Last ingested by Listed: Nov 14, 2026, 18:14 ET. No prices; not investment advice.
